MMolecular Therapy Advances3/1/2026Low Density Lipoproteins (LDLs) in human serum competitively inhibit the binding and entry of Vesicular Stomatitis VirusRianna Vandergaast·Stephen J. Russell·Christopher M. Ziegler·Samantha Marie Johnson·Gopal Naik Nenavath·Luke Schnebeck·Riya NarjariRead at Molecular Therapy AdvancesTagsVirology and Viral DiseasesEpidemiology
